Articles Archives - Page 127 of 761

ThursdayMay 23, 2024 12:00 pm

DealFlow Events Presents the 5th Annual Reg A & Crowdfunding Conference June 20, 2024

The 5th Annual Reg A & Crowdfunding Conference will take place at New York’s luxurious Westchester Country Club on June 20 The fifth annual conference will play host to investors, entrepreneurs and financiers as we to delve into the latest trends within the equity capital markets industry This year’s conference will feature a number of keynote presentations and speakers, including on topics such as the structuring and efficient marketing of Reg A+ and Crowdfunding deals Learn from (and network with) experts who raise capital with these powerful tools Equity capital markets have long been an attractive source of growth capital…

ThursdayMay 23, 2024 11:15 am

4th Annual Psychedelic Therapeutics and Drug Development Conference Comes to Boston, MA

Researchers and leaders in academia, industry, the non-profit sector, and government organizations are invited to attend the 4th Annual Psychedelic Therapeutics and Drug Development Conference being held May 23-24, 2024, in Boston, MA. The conference focuses on discussing the hurdles as well as challenges in the research and development of psychedelics for various health conditions. Join the experts for this two-day conference that involves exploration, learning, discussion, and networking. Specific areas of discussion will include: Targets for novel drug development Toxicology studies and considerations The dosage debate and new evidence Second generation psychedelic drug design FDA regulatory guidance The speaker…

ThursdayMay 23, 2024 10:30 am

DGE 8th Digital Strategy & Innovation for Medical Affairs To Open New Pathways of Transformation

DGE invites medical affairs and healthcare professionals to attend the 8th Digital Strategy & Innovation For Medical Affairs summit in Philadelphia on June 5-6, 2024. Experts attending the conference will offer insights to leverage digital technology for building patient and caregiver relationships, and for maintaining market position. The summit is organized by Dynamic Global Events (“DGE”), a life science leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the pharma, biotechnology, healthcare, medical devices, and allied industries. The event agenda covers: Incorporating AI into patient outreach Identifying the most important tools…

ThursdayMay 23, 2024 9:45 am

SenesTech Inc. (NASDAQ: SNES) Releases Q1 2024 Financial Results Reflecting ‘Outstanding Growth’

SenesTech reported record Q1 2024 revenue of $415,000, an increase of 78% compared to Q1 2023 and a 41% sequential increase from Q4 2023 The company attributes this growth to the introduction in January 2024 of Evolve(TM), its soft-bait product featuring breakthrough, next-generation technology that targets rat populations by using non-lethal methods to restrict fertility SenesTech is anticipating additional growth following the completion of an efficacy study providing data requested by certain state and international regulators, as this could open new markets that were previously inaccessible In May, the company also launched Evolve(TM) Mouse, a soft-bait product to control mouse…

ThursdayMay 23, 2024 9:00 am

HealthLynked Corp. (HLYK) Can Add Tens-of-thousands of Members by Improving Care for Students vis-à-vis its Affinity Marketing Efforts to U.S. Universities

The HealthLynked platform provides secure and quick access for patient/doctor records communication, supporting all types of health related utilization, including telemedicine and remote student applications University health clinics often face challenges when transferring medical records – and this limits coordinated care for students The HealthLynked platform provides a streamlined approach to medical records access, allowing students to securely share their health information with relevant parties HealthLynked (OTCQB: HLYK) is a company on a mission to build a superior healthcare system through the efficient integration of patient histories, genetic data, and demographic insights, into a sophisticated AI-driven platform that streamlines patient…

WednesdayMay 22, 2024 10:30 am

DGE 4th PRC Performance Optimization Summit To Unite The Best Minds In The Business

Life science professionals responsible for promotional review, marketing, labelling, communications, and compliance are invited to attend DGE’s 4th PRC Performance Optimization Summit being held in Philadelphia June 5-6, 2024. The most detailed industry event available on this subject, participants will focus in-depth on ways to ensure the best regulatory outcomes. DGE (Dynamic Global Events), a life science leader in organizing B2B events, strives to meet the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries. DGE events specialize in offering a robust platform where professionals can network, connect, and explore business opportunities in a…

WednesdayMay 22, 2024 9:00 am

Mountain Top Properties Inc. (MTPP) Poised to Capitalize on Booming Tri-State Real Estate Market

Hamptons and Tri-State real estate prices keep rising due to high demand and declining property inventory MTPP positioned to capitalize on current market conditions via strategy that fuses traditional real estate and PropTech investments MTPP recently initiated a Regulation D offering to raise up to $7.5 million for expansion of development projects in the Hamptons and PropTech investments The Hamptons and broader Tri-State real estate markets continue their unprecedented upward trajectory, driven by the growing demand for properties amid a declining inventory. Mountain Top Properties (OTC: MTPP), a diversified real estate holding company, is strongly positioned to leverage current conditions…

TuesdayMay 21, 2024 11:15 am

Torr Metals Inc. (TSX.V: TMET): Shaping the Future of Precious Metals with Gold and Copper

Central banks bought 290 metric tons of gold during Q1 2024, while copper prices continue to climb as part of the green energy transition Torr Metals has three highly prospective Canadian gold and copper projects including Kolos, a major intrusive complex considered the last remaining to be tested in the southern Quesnel Trough with similarities to the Copper Mountain porphyry deposit; and Filion, an underexplored gold-bearing greenstone belt adjacent to the Trans-Canada Highway in northern Ontario TMET insiders are holding tight, controlling about 40% of the company’s outstanding shares as the stock enters a new uptrend The global market is…

TuesdayMay 21, 2024 10:30 am

GEMXX Corp. (GEMZ) Expands to Oil and Gas Exploration Ventures, Creating New Strategic Partnerships in Industry

In an expansion of operations, GEMXX plans to finance the exploration of extensive oil reserves, specifically targeting giant fields with reserves of 500 million barrels and super-giant fields with over 3 billion barrels located primarily in Latin America By leveraging a comprehensive network in the oil and gas sector, GEMXX plans to develop strong strategic partnerships and secure funding to propel exploration efforts quickly GEMXX has also announced Richard Clowater as the new Chief Executive Officer and Chairman of the Board, and the appointment of Deane Preston to its Board of Directors, effective May 15, 2024 GEMXX (OTC: GEMZ), an…

TuesdayMay 21, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Key Operational Highlights as part of First Quarter 2024 Financial Results

Clene presented clinical data at the 2024 American Academy of Neurology (“AAN”) Annual Meeting, demonstrating that long-term CNM-Au8® treatment resulted in significant evidence of repair and remyelination across multiple paraclinical endpoints Clene entered into a sub-award grant agreement with Columbia University under the previously announced National Institute of Health (“NIH”) Grant Clene announced the publication of "Protein Corona Composition of Gold Nanocatalysts" in the ACS Pharmacology & Translational Science journal Clene (NASDAQ: CLNN), a late-stage clinical biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), along with its wholly-owned subsidiary…

Site Search

Company Search

Category: Articles